EDGAR Filing Documents for 0001104659-13-092280

Form 8-K - Current report:

SEC Accession No. 0001104659-13-092280

Filing Date

2013-12-24

Accepted

2013-12-24 13:31:39

Documents

Period of Report

2013-12-19

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a13-26953_138k.htm	8-K	79025
2	EX-10.1	a13-26953_13ex10d1.htm	EX-10.1	150184
3	EX-10.2	a13-26953_13ex10d2.htm	EX-10.2	142099
4	EX-10.3	a13-26953_13ex10d3.htm	EX-10.3	142230
5	EX-10.4	a13-26953_13ex10d4.htm	EX-10.4	406416
6	EX-99.1	a13-26953_13ex99d1.htm	EX-99.1	8265
	Complete submission text file	0001104659-13-092280.txt		929623

Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130

Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900

Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)